General gastro Flashcards
What is acute upper gastrointestinal bleeding most commonly due to
Peptic ulcer disease
Oeseophageal varices
Risk assessment in upper gastrointestinal bleeding
Use the blatchford score at first assessment(admission risk marker - patients with 0 may be considered for early discharge)
Full rockall score after endoscopy
Immediate management of acute GI bleed
A-E resus
Platelet transfusion if actively bleeding
FFP if low fibrinogen or APTT elevated
Immediate endoscopy after resuscitation within 24 hrs
Why should PPIs not be prescribed in an acute GI bleed
Should not be prescribed until post-endoscopy as they may mask the site of bleeding
Management of variceal bleeding
terlipressin and prophylactic antibiotics should be given to patients at presentation (i.e. before endoscopy)
band ligation should be used for oesophageal varices and injections of N-butyl-2-cyanoacrylate for patients with gastric varices
transjugular intrahepatic portosystemic shunts (TIPS) should be offered if bleeding from varices is not controlled with the above measures
Symptoms and signs of giardiasis
Asymptomatic Watery malodorous diarrhoea Abdominal cramps and distension Nausea Epigastric discomfort
What is giardiasis often accompanied by
Acquired lactose-intolerance
Transmission of giardiasis
Some trophozoites transform into environmentally resistant cysts that are spread by focal-oral route
Waterborne transmission is the major source of infection but transmission can occur from ingestion of contaminated food or direct person-to-person contact
Diagnosis of giardiasis
Enzyme immunoassay for antigen or molecular test for parasite DNA in stool
Microscopic examination of stool(characteristic trophozoites or cysts in stool are diagnostic)
Treatment for giardiasis
Metronidazole(warn to not drink alcohol to avoid disulfiram-like reaction)
What is Barrett’s oesophagus
Metaplasia of the lower oesophageal mucosa, with the usual squamous epithelium being replaced by columnar epithelium
What type of cancer does Barrett’s oesophagus predispose to
Oesophageal adenocarcinoma
Risk factors for Barrett’s oesophagus
GORD is the single strongest risk factor
male gender (7:1 ratio)
smoking
central obesity
Mx of Barrett’s oesophagus
endoscopic surveillance with biopsies(recommended for patients with metaplasia every 3-5 yrs)
high-dose proton pump inhibitor
Options if dysplasia of any grade is identified in the oesophagus
Endoscopic mucosal resection
Radiofrequency ablation
Most common site for UC
Rectum(inflammation always starts there)
Never spreads beyond ileocaecal valve
Initial presentation of UC
bloody diarrhoea urgency tenesmus abdominal pain, particularly in the left lower quadrant extra-intestinal features
Extra-intestinal features of UC
Pauciarticular arthritis Asymmetric erythema nodosum Episcleritis Osteoporosis PSC Uveitis
Pathology features of UC
red, raw mucosa, bleeds easily
no inflammation beyond submucosa (unless fulminant disease)
widespread ulceration with preservation of adjacent mucosa which has the appearance of polyps
inflammatory cell infiltrate in lamina propria
neutrophils migrate through the walls of glands to form crypt abscesses
depletion of goblet cells and mucin from gland epithelium
granulomas are infrequent
What might a barium enema show in UC
loss of haustrations
superficial ulceration, ‘pseudopolyps’
long standing disease: colon is narrow and short -‘drainpipe colon’
Classification of UC
mild: < 4 stools/day, only a small amount of blood
moderate: 4-6 stools/day, varying amounts of blood, no systemic upset
severe: >6 bloody stools per day + features of systemic upset (pyrexia, tachycardia, anaemia, raised inflammatory markers)
What is proctitis
Inflammation of the rectum
Inducing remission in proctitis
topical (rectal) aminosalicylate: for distal colitis rectal mesalazine has been shown to be superior
if remission is not achieved within 4 weeks, add an oral aminosalicylate
if remission still not achieved add topical or oral corticosteroid
Inducing remission in proctosigmoiditis and left-sided ulcerative colitis
Topical aminosalicylate
If remission is not achieved within 4 weeks, an oral corticosteroid for 4 to 8 weeks in addition to the high-dose aminosalicylate should be offered.
Management of mild-to-moderate ulcerative colitis that is extensive
A topical aminosalicylate and a high-dose oral aminosalicylate
If remission is not achieved within 4 weeks, stop topical aminosalicylate treatment and offer a high-dose oral aminosalicylate and 4 to 8 weeks of an oral corticosteroid.
Treatment of acute severe ulcerative colitis
IV corticosteroids(hydrocortisone or methylpred)
Assess need for surgery
IV cyclosporin if corticosteroids are contra-indicated
Maintaining remission in mild, moderate or severe ulcerative colitis
maintenance therapy with an aminosalicylate is recommended in most patients. Corticosteroids are not suitable for maintenance treatment because of their side-effects.
Contra-indications of mesalazine
Blood clotting abnormalities
Side effects of aminosalicylates
Arthralgia
GI discomfort
Leucopenia
Nausea
Which parameters should be monitored before starting an oral aminosalicylate
Renal function
Trigger factors for UC
Stress
Medications(NSAIDs, antibiotics)
Cessation of smoking
Area commonly affected by crohn’s disease
Terminal ileum and colon
Complications of crohn’s disease
Intestinal strictures Abscesses in the wall of intestine Fistulae Anaemia Malnutrition Colorectal and small bowel cancers
Extra-intestinal features of crohn’s
Arthritis(pauciarticular) Asymmetric erythema nodosum Episcleritis(more common CD) Osteoporosis Mouth ulcers Perianal disease